Teva Pharmaceutical Industries (TEVA) Goodwill & Intangibles: 2009-2025
Historic Goodwill & Intangibles for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $19.9 billion.
- Teva Pharmaceutical Industries' Goodwill & Intangibles fell 4.78% to $19.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.9 billion, marking a year-over-year decrease of 4.78%. This contributed to the annual value of $19.6 billion for FY2024, which is 13.29% down from last year.
- Teva Pharmaceutical Industries' Goodwill & Intangibles amounted to $19.9 billion in Q3 2025, which was down 1.05% from $20.1 billion recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Goodwill & Intangibles registered a high of $28.7 billion during Q1 2021, and its lowest value of $7.2 billion during Q2 2022.
- In the last 3 years, Teva Pharmaceutical Industries' Goodwill & Intangibles had a median value of $21.3 billion in 2024 and averaged $21.4 billion.
- Its Goodwill & Intangibles has fluctuated over the past 5 years, first plummeted by 74.85% in 2022, then spiked by 218.37% in 2023.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Goodwill & Intangibles stood at $25.1 billion in 2021, then declined by 6.58% to $23.4 billion in 2022, then fell by 3.77% to $22.6 billion in 2023, then fell by 13.29% to $19.6 billion in 2024, then dropped by 4.78% to $19.9 billion in 2025.
- Its Goodwill & Intangibles stands at $19.9 billion for Q3 2025, versus $20.1 billion for Q2 2025 and $19.7 billion for Q1 2025.